Literature DB >> 18178802

Hypokalemic nephropathy is associated with impaired angiogenesis.

Sirirat Reungjui1, Carlos A Roncal, Waichi Sato, Olena Y Glushakova, Byron P Croker, Shin-Ichi Suga, Xiaosen Ouyang, Kriang Tungsanga, Takahiko Nakagawa, Richard J Johnson, Wei Mu.   

Abstract

Hypokalemic nephropathy is associated with alterations in intrarenal vasoactive substances, leading to vasoconstriction, salt-sensitivity, and progression of interstitial fibrosis. In this study, we investigated whether hypokalemic nephropathy might also involve impaired renal angiogenesis. Sprague-Dawley rats that were fed low-potassium diets developed peritubular capillary loss that began in the inner stripe of the outer medulla (week 2) and progressed to the outer stripe of the outer medulla (week 4) and cortex (week 12). These changes were associated with increased macrophage infiltration, increased expression of both monocyte chemoattractant protein-1 and TNF-alpha, and a loss of vascular endothelial growth factor and endothelial nitric oxide synthase. Renal thiobarbituric acid-reactive substances, markers of oxidative stress, were increased late in disease. In conclusion, hypokalemic nephropathy is associated with impaired renal angiogenesis, evidenced by progressive capillary loss, reduced endothelial cell proliferation, and loss of VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178802      PMCID: PMC2391040          DOI: 10.1681/ASN.2007030261

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

Review 1.  Role of the microvascular endothelium in progressive renal disease.

Authors:  Duk-Hee Kang; John Kanellis; Christian Hugo; Luan Truong; Sharon Anderson; Dontscho Kerjaschki; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

Review 2.  Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors.

Authors:  S Dimmeler; A M Zeiher
Journal:  Regul Pept       Date:  2000-06-30

3.  Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency.

Authors:  Shin-Ichi Suga; Marilda Mazzali; Patricio E Ray; Duk-Hee Kang; Richard J Johnson
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

4.  Inhibitory effect of polyphenol cyanidin on TNF-alpha-induced apoptosis through multiple signaling pathways in endothelial cells.

Authors:  Jin-Wen Xu; Katsumi Ikeda; Yukio Yamori
Journal:  Atherosclerosis       Date:  2006-10-10       Impact factor: 5.162

5.  Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.

Authors:  Darren J Kelly; Jennifer L Wilkinson-Berka; Sharon D Ricardo; Alison J Cox; Richard E Gilbert
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

6.  Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity.

Authors:  S I Suga; M I Phillips; P E Ray; J A Raleigh; C P Vio; Y G Kim; M Mazzali; K L Gordon; J Hughes; R J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2001-10

7.  Expression of insulin-like growth factor-I and transforming growth factor-beta in hypokalemic nephropathy in the rat.

Authors:  T Tsao; J Fawcett; F C Fervenza; F W Hsu; P Huie; R K Sibley; R Rabkin
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

8.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

9.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Authors:  Duk-Hee Kang; Jeremy Hughes; Marilda Mazzali; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

10.  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Authors:  Duk-Hee Kang; Alison H Joly; Se-Woong Oh; Christian Hugo; Dontscho Kerjaschki; Katherine L Gordon; Marilda Mazzali; J Ashley Jefferson; Jeremy Hughes; Kirsten M Madsen; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

View more
  22 in total

1.  Eating disorders should be considered in the differential diagnosis of patients presenting with acute kidney injury and electrolyte derangement.

Authors:  Ben Edward Michael Talbot; Sarah H A Lawman
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.

Authors:  Wolfgang Lieb; Justin P Zachariah; Vanessa Xanthakis; Radwan Safa; Ming-Huei Chen; Lisa M Sullivan; Martin G Larson; Holly M Smith; Qiong Yang; Gary F Mitchell; Joseph A Vita; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Circ Cardiovasc Genet       Date:  2010-03-26

3.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

Review 4.  Epithelial Na+ channel (ENaC), hormones, and hypertension.

Authors:  James K Bubien
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

Review 5.  A case of primary aldosteronism revealed after renal transplantation.

Authors:  Ewout J Hoorn; Dennis A Hesselink; Marcia M Kho; Joke I Roodnat; Willem Weimar; Jan L van Saase; Anton H van den Meiracker; Robert Zietse
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

6.  Patients with hypokalemia develop WNK bodies in the distal convoluted tubule of the kidney.

Authors:  Martin N Thomson; Wolfgang Schneider; Kerim Mutig; David H Ellison; Ralph Kettritz; Sebastian Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-28

7.  A physiologic-based approach to the treatment of a patient with hypokalemia.

Authors:  Abdo Asmar; Rajesh Mohandas; Charles S Wingo
Journal:  Am J Kidney Dis       Date:  2012-09       Impact factor: 8.860

8.  Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Authors:  Georges N Nakhoul; Haiquan Huang; Susana Arrigain; Stacey E Jolly; Jesse D Schold; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Nephrol       Date:  2015-07-25       Impact factor: 3.754

Review 9.  Narrative review: evolving concepts in potassium homeostasis and hypokalemia.

Authors:  Megan Greenlee; Charles S Wingo; Alicia A McDonough; Jang-Hyun Youn; Bruce C Kone
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Rapid development of vasopressin resistance in dietary K+ deficiency.

Authors:  Lama Al-Qusairi; P Richard Grimm; Ava M Zapf; Paul A Welling
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.